HomeQuestion
How would you treat a case of mixed histology NSCLC/SCLC that rapidly progresses following chemoradiation and durvalumab?
2 Answers
Mednet Member
Medical Oncology · Wexner Medical Center at The Ohio State University
In recent weeks, I have had several patients progressing on or immediately after stopping durvalumab following chemoradiation—a frustrating and difficult situation. In the patients I saw (without mixed histology), I discussed clinical trials of post-immune therapy progression. The particular questio...